The BalancedInvestor Club

TWST Market Analysis

Overview

Fundamentals

P/E ratio—
EPS (TTM)$-1.270.0% YoY
Profit margin-19.6%HEALTHCARE
Market cap$3.70BMid cap

Wall Street coverage

$55.00median target· current $44.67 (+23.1%)10 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
—
PEG ratio
—
P/B
8.12
P/S (TTM)
9.46
EV/EBITDA
-35.26

Profitability & growth

ROE (TTM)
-16.8%
Operating margin
-31.7%
Revenue growth YoY
16.9%
Dividend yield
—
Beta
2.21
Last earnings
Apr 30, 2026 · Estimate $-0.47 · Reported $0.00
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Twist Bioscience Corp

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company is headquartered in South San Francisco, California.

Classification

Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
681 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CA
Fiscal year end
September
Latest quarter
Dec 31, 2025
Market cap$3.70B
Shares outstanding$61.3M
52W high$66.06
52W low$23.30

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer